USPTO serial 87612496
THEOREMDX
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- SAUNDERS, ANDREA DAWN
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with THEOREMDX?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Robert P. Ziemian
ROBERT P. ZIEMIAN HAYNES AND BOONE, LLP2323 VICTORY AVE STE 700DALLAS, TX 75219UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Scientific instruments for analyzing analytes in blood; scientific instruments for analyzing analytes in saliva; scientific instruments for analyzing analytes in urine; scientific instruments for analyzing analytes in semen; scientific instruments for analyzing analytes in bodily fluids; scientific instruments for analyzing blood samples to detect diseases; scientific instruments for analyzing saliva samples to detect diseases; scientific instruments for analyzing urine samples to detect diseases; scientific instruments for analyzing semen samples to detect diseases; scientific instruments for analyzing bodily fluid samples to detect diseases | ACTIVE | — |
| 010 | Medical diagnostic devices for determining analytes in blood; Medical diagnostic devices for determining analytes saliva; Medical diagnostic devices for determining analytes in urine; Medical diagnostic devices for determining analytes in semen; Medical diagnostic devices for determining analytes in bodily fluids; Medical diagnostic devices for diagnosing infectious diseases, cancer, cardiovascular diseases, neuro-cardiovascular diseases and immunological diseases from a blood sample; Medical diagnostic devices for diagnosing infectious diseases, cancer, cardiovascular diseases, neuro-cardiovascular diseases and immunological diseases from a salvia sample; Medical diagnostic devices for diagnosing infectious diseases, cancer, cardiovascular diseases, neuro-cardiovascular diseases and immunological diseases from a urine sample; Medical diagnostic devices for diagnosing infectious diseases, cancer, cardiovascular diseases, neuro-cardiovascular diseases and immunological diseases from a semen sample; Medical diagnostic devices for diagnosing infectious diseases, cancer, cardiovascular diseases, neuro-cardiovascular diseases and immunological diseases from a bodily fluid sample | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by OvaGene Oncology, Inc.
- Other trademarks owned by OvaGene Oncology, Inc.
- Other trademarks owned by THEOREMDX INC.
- Other trademarks in Class 009
- Other trademarks in Class 010
- Similar marks named THEOREMDX
- Prosecution event MAB6 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 8, 2020 | MAB6 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Jun 8, 2020 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Jul 9, 2019 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jul 5, 2019 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Jul 5, 2019 | EXT2 | SOU EXTENSION 2 FILED | — |
| Jul 5, 2019 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Mar 1, 2019 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Feb 27, 2019 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Feb 27, 2019 | EXT1 | SOU EXTENSION 1 FILED | — |
| Feb 27, 2019 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Sep 17, 2018 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Sep 17, 2018 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Sep 11, 2018 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Jul 25, 2018 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Jul 17, 2018 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jul 17, 2018 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jun 27, 2018 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jun 14, 2018 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Jun 11, 2018 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 11, 2018 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jun 11, 2018 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jun 11, 2018 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jun 11, 2018 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jun 4, 2018 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 4, 2018 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 29, 2018 | ALIE | ASSIGNED TO LIE | — |
| May 22, 2018 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 21, 2017 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 21, 2017 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 21, 2017 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 21, 2017 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 22, 2017 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Sep 21, 2017 | NWAP | NEW APPLICATION ENTERED | — |